The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Before the discovery of insulin, diabetes was considered a mysterious and often fatal disease. Characterized by symptoms such ...

Top 10 Sneaky Signs You May Be Insulin Resistant #sneaky #signs #insulin #resistant #health #healthtips #healthapta Do you ...

Putting pregnant women who develop diabetes on a reduced calorie diet could help them avoid the need for insulin injections ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket ...

More than 7,500 students with Type 1 diabetes enter college every year, and the number is only growing. At the University of ...

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

The team is now focused on understanding how genetic factors influence lipid profiles and what role they play in metabolic ...

FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.